Medtronic plc

MDT - CIK 0001613103

Market cap$103.24 B

Rank#146

SEC filings998

Medtronic plc trades as MDT and has a market capitalization of $103.24 B, making it the #146 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $33.54B, up 3.6% from the prior year and net income of $4.66B. This page tracks Medtronic plc through 998 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Revenue (latest FY)$33.54BFY 2025

Net income (latest FY)$4.66BFY 2025

Operating cash flow (latest FY)$7.04BFY 2025

Total assets (latest FY)$91.68BFY 2025

Net margin13.9%latest FY

Financial performance

Over the last 9 fiscal years Medtronic plc's revenue grew from $28.83B to $33.54B, a compound annual growth rate of 1.7%. Net profit margin expanded from 12.3% to 13.9% over the same period - every figure below comes from the company's audited annual filings.

MDT annual revenueView details

Key statistics

Market cap: $103.24 B
Share price (derived)market cap / shares outstanding: $80.41
P/E ratio (trailing FY): 22.1
EPS (diluted)FY 2025: $3.61
Shares outstandingas of 2026-02-18: 1.28B
Total equityas of 2026-01-23: $48.98B
Return on equity: 9.5%
Cash & equivalentsas of 2026-01-23: $1.15B

Latest filings

Filing	Type	Filed
Major company event	8-K	2026-05-18
SCHEDULE 13G	-	2026-05-06
Insider trade	4	2026-05-04
Insider trade	4	2026-04-29
Insider trade	4	2026-04-29
Insider trade	4	2026-04-29
Insider trade	4	2026-04-29
Insider trade	4	2026-04-29

Browse the full filing history (998 filings)

Recent press releases

Medtronic announces CE Mark for Stealth AXiS™ surgical system - Apr 28, 20262026-04-28
Medtronic announces CE Mark for Stealth AXiS™ surgical system
Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues - Apr 25, 20262026-04-25
Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026 - Apr 13, 20262026-04-13
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026
Medtronic reports strong third quarter fiscal 2026 results with highest ...
Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters · Revenue of $9.0 billion, ...
Medtronic reports first quarter fiscal 2026 financial results
Medtronic reports first quarter fiscal 2026 financial results ; Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as ...

Similar companies

The largest companies sharing Medtronic plc's SEC industry classification (electromedical & electrotherapeutic apparatus).

MASIMasimo Corporation$9.43 B MDT vs MASI

LIVNLivaNova PLC$4.29 B MDT vs LIVN

ITGRInteger Holdings Corporation$3.13 B MDT vs ITGR

TMDXTransMedics Group, Inc.$2.59 B MDT vs TMDX

AXGNAxogen, Inc.$2.19 B MDT vs AXGN

Frequently asked questions

What is Medtronic plc's market cap?

Medtronic plc (MDT) has a market capitalization of $103.24 B as of 2026-06-10, ranking #146 among US-listed companies.

How much revenue does Medtronic plc make?

Medtronic plc reported revenue of $33.54B for fiscal year 2025, an increase of 3.6% year over year.

Is Medtronic plc profitable?

Yes. Medtronic plc reported net income of $4.66B in its latest fiscal year.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.